Customer Relationship Management, Technology, Banks, Customers

Non alcoholic fatty liver disease (NAFLD) is a clinicopathological syndrome that is closely associated with obesity, dyslipidaemia, insulin resistance and diabetes mellitus, thus suggesting that NAFLD represents another component of metabolic syndrome. It is postulated that NAFLD, like metabolic syndrome, is associated with increased risk of atherosclerosis. In the present study 100 healthy subjects with incidental NAFLD were subjected to detailed history, physical examination including body-mass index (BMI) and biochemical investigations including renal function tests, lipid profile and liver function tests. Proteinuria was measured in these subjects to evaluate microvascular renal damage. Subjects with alcoholic liver disease, chronic viral hepatits, renal disease, etc were excluded. The results obtained were entered in Microsoft excel and was analysed using Epi info software version 7. The statistical analysis was done by using the ANNOVA test. Results showed there was highly significant (p<0.001) correlation between proteinuria and NAFLD. This correlation was more positive and progressive with increased grades of NAFLD. This signifies increased renal microvascular damage and progression to chronic kidney disease (CKD) in patients with NAFLD. The prevalence of NAFLD is increasing mainly due to increasing obesity and metabolic syndrome. The potential clinical implications of these finding for patient care are the detection of NAFLD by routine ultrasonography (USG) especially in obese and urine analysis for proteinuria in these persons. This will alert the clinician about cardiovascular risks and risk of CKD in these apparently healthy persons.